Corbus Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -49 | -49 | -100 | |
EBITDA | -24,304 | -20,506 | -23,292 | -17,562 |
EBIT | -20,555 | -23,342 | -17,662 | |
Net Income | -22,969 | -20,555 | -23,342 | -17,662 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -25,577 | -15,928 | -15,550 | -16,599 |
Cash | 26,046 | 28,492 | 26,983 | 20,044 |
Basic Shares | 13,317 | 13,317 | 12,307 | 12,240 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -233 | -600 | -31,167 | -1,487 |
EBITDA | -78,304 | -37,737 | -40,105 | -38,726 |
EBIT | -78,537 | -38,337 | -40,746 | -40,214 |
Net Income | -78,537 | -40,209 | -44,604 | -55,833 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -64,498 | -41,794 | -36,100 | -37,557 |
Cash | 28,492 | 17,198 | 13,724 | 17,002 |
Basic Shares | 13,317 | 10,915 | 4,327 | 4,170 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$1.23 |
2025-12-31 | -$1.25 |
2025-09-30 | -$1.90 |
2025-06-30 | -$1.44 |